Theravance Biopharma, Inc. - Ordinary Share $0.00001 Par Value (TBPH)
CUSIP: G8807B106
Q4 2024 13F Holders as of 31 Dec 2024
- Type / Class
- Equity / Ordinary Share $0.00001 Par Value
- Shares outstanding
- 51,428,000
- Total 13F shares
- 44,887,720
- Share change
- -897,944
- Total reported value
- $422,397,233
- Put/Call ratio
- 50%
- Price per share
- $9.41
- Number of holders
- 128
- Value change
- -$6,899,094
- Number of buys
- 61
- Number of sells
- 47
Quarterly Holders Quick Answers
What is CUSIP G8807B106?
CUSIP G8807B106 identifies TBPH - Theravance Biopharma, Inc. - Ordinary Share $0.00001 Par Value in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP G8807B106:
Top shareholders of TBPH - Theravance Biopharma, Inc. - Ordinary Share $0.00001 Par Value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Weiss Asset Management LP |
3/4/5
13F
|
10%+ Owner · Company |
14%
from 13F
|
7,457,060
|
$76,733,147 | — | 19 Sep 2022 | |
| Madison Avenue Partners, LP |
13F
|
Company |
18%
|
9,511,150
|
$76,659,869 | — | 30 Sep 2024 | |
| Eli Samaha |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
9,511,150
|
$74,186,970 | — | 07 Aug 2024 | |
| Newtyn Management, LLC |
13F
|
Company |
8.7%
|
4,499,066
|
$36,262,472 | — | 30 Sep 2024 | |
| BlackRock, Inc. |
13F
|
Company |
7.3%
|
3,731,305
|
$30,074,318 | — | 30 Sep 2024 | |
| Irenic Capital Management LP |
13F
|
Company |
5.4%
|
2,760,948
|
$22,253,241 | — | 30 Sep 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
4%
|
2,051,689
|
$16,536,613 | — | 30 Sep 2024 | |
| Park West Asset Management LLC |
13F
|
Company |
3.6%
|
1,862,988
|
$15,015,683 | — | 30 Sep 2024 | |
| STATE STREET CORP |
13F
|
Company |
2.3%
|
1,191,621
|
$9,604,465 | — | 30 Sep 2024 | |
| Oasis Management Co Ltd. |
13F
|
Company |
2.2%
|
1,115,765
|
$8,993,066 | — | 30 Sep 2024 | |
| Camber Capital Management LP |
13F
|
Company |
1.9%
|
1,000,000
|
$8,060,000 | — | 30 Sep 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.7%
|
857,979
|
$6,916,069 | — | 30 Sep 2024 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
1.5%
|
764,765
|
$6,164,006 | — | 30 Sep 2024 | |
| Pictet Asset Management Holding SA |
13F
|
Company |
1.3%
|
684,892
|
$5,547,317 | — | 30 Sep 2024 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
1.1%
|
576,447
|
$4,646,163 | — | 30 Sep 2024 | |
| Frank Pasqualone |
3/4/5
|
SVP, CHIEF BUSINESS OFFICER |
—
class O/S missing
|
429,783
|
$4,422,467 | — | 19 Nov 2021 | |
| MORGAN STANLEY |
13F
|
Company |
0.96%
|
495,813
|
$3,996,253 | — | 30 Sep 2024 | |
| Andrew A. Hindman |
3/4/5
|
SVP, CHIEF FINANCIAL OFFICER |
—
class O/S missing
|
384,714
|
$3,958,707 | — | 18 Nov 2022 | |
| Kenneth R. Pitzer |
3/4/5
|
SVP, PROD STRAT & COMM PLNG |
—
class O/S missing
|
380,123
|
$3,911,466 | — | 18 Feb 2022 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.91%
|
468,879
|
$3,779,166 | — | 30 Sep 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.89%
|
458,409
|
$3,694,882 | — | 30 Sep 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.87%
|
447,092
|
$3,603,562 | — | 30 Sep 2024 | |
| Philip D. Worboys |
3/4/5
|
SVP, RESEARCH & TRANSL SCIENCE |
—
class O/S missing
|
330,752
|
$3,403,438 | — | 19 Nov 2021 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.75%
|
383,782
|
$3,093,282 | — | 30 Sep 2024 | |
| Bradford J. Shafer |
3/4/5
|
EVP, Gen. Counsel, Secretary |
—
class O/S missing
|
277,831
|
$2,858,881 | — | 20 Aug 2021 | |
| Richard A. Graham |
3/4/5
|
SVP, RESEARCH & DEVELOPMENT |
—
class O/S missing
|
314,915
|
$2,809,042 | — | 20 Feb 2024 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.59%
|
305,480
|
$2,462,169 | — | 30 Sep 2024 | |
| Vijay Sabesan |
3/4/5
|
SVP, TECHNICAL OPERATIONS |
—
class O/S missing
|
235,524
|
$2,423,542 | — | 19 Nov 2021 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.57%
|
291,876
|
$2,352,521 | — | 30 Sep 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.56%
|
289,789
|
$2,335,700 | — | 30 Sep 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.52%
|
266,879
|
$2,151,045 | — | 30 Sep 2024 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.51%
|
262,896
|
$2,118,942 | — | 30 Sep 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.46%
|
234,556
|
$1,890,521 | — | 30 Sep 2024 | |
| GSA CAPITAL PARTNERS LLP |
13F
|
Company |
0.45%
|
229,780
|
$1,852,000 | — | 30 Sep 2024 | |
| MACQUARIE GROUP LTD |
13F
|
Company |
0.41%
|
208,783
|
$1,683,000 | — | 30 Sep 2024 | |
| TUDOR INVESTMENT CORP ET AL |
13F
|
Company |
0.38%
|
196,578
|
$1,584,419 | — | 30 Sep 2024 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.37%
|
191,329
|
$1,542,112 | — | 30 Sep 2024 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.29%
|
150,060
|
$1,209,484 | — | 30 Sep 2024 | |
| Burton G. Malkiel |
3/4/5
|
Director |
—
mixed-class rows
|
137,633
mixed-class rows
|
$1,189,411 | — | 02 May 2023 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.28%
|
144,575
|
$1,165,274 | — | 30 Sep 2024 | |
| Ann Brady |
3/4/5
|
PRESIDENT, TBIL |
—
class O/S missing
|
110,319
|
$1,135,183 | — | 18 Feb 2022 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.24%
|
121,061
|
$975,751 | — | 30 Sep 2024 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.23%
|
117,505
|
$947,090 | — | 30 Sep 2024 | |
| STATE OF WISCONSIN INVESTMENT BOARD |
13F
|
Company |
0.22%
|
114,286
|
$921,145 | — | 30 Sep 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.22%
|
112,699
|
$908,354 | — | 30 Sep 2024 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.22%
|
111,632
|
$899,754 | — | 30 Sep 2024 | |
| ALGERT GLOBAL LLC |
13F
|
Company |
0.21%
|
105,609
|
$851,000 | — | 30 Sep 2024 | |
| Trexquant Investment LP |
13F
|
Company |
0.19%
|
100,257
|
$808,071 | — | 30 Sep 2024 | |
| William D. Young |
3/4/5
|
Director |
—
mixed-class rows
|
106,010
mixed-class rows
|
$802,723 | — | 26 Apr 2022 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.19%
|
98,951
|
$797,545 | — | 30 Sep 2024 |
Institutional Holders of Theravance Biopharma, Inc. - Ordinary Share $0.00001 Par Value (TBPH) as of Q4 2024
As of 31 Dec 2024,
Theravance Biopharma, Inc. - Ordinary Share $0.00001 Par Value (TBPH) was held by
128 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
44,887,720 shares.
The largest 10 holders included
Madison Avenue Partners, LP, Weiss Asset Management LP, Newtyn Management, LLC, BlackRock, Inc., Irenic Capital Management LP, VANGUARD GROUP INC, Park West Asset Management LLC, STATE STREET CORP, Oasis Management Co Ltd., and Camber Capital Management LP.
This page lists
128
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2024 vs Q3 2024 Across Filers
Q3 2024 holders
118
Q4 2024 holders
128
Holder diff
10
| Investor | Q3 2024 Shares | Q4 2024 Shares | Share Diff | Share Chg % | Q3 2024 Value $ | Q4 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.